Financialsexperimental
WELLS FARGO & COMPANY/MN (WFC-PA). Every figure is as filed in the company's 10-Q and 10-K reports. Quarters a filing does not report on their own are worked out from its year-to-date figures and marked *.
USD in millions
| Cash Flow | Q2 FY26 30 Jun 2026 | Q1 FY26 31 Mar 2026 | Q4 FY25 31 Dec 2025 | Q3 FY25 30 Sept 2025 | Q2 FY25 30 Jun 2025 | Q1 FY25 31 Mar 2025 | Q4 FY24 31 Dec 2024 | Q3 FY24 30 Sept 2024 | Q2 FY24 30 Jun 2024 | Q1 FY24 31 Mar 2024 | Q4 FY23 31 Dec 2023 | Q3 FY23 30 Sept 2023 | Q2 FY23 30 Jun 2023 | Q1 FY23 31 Mar 2023 | Q4 FY22 31 Dec 2022 | Q3 FY22 30 Sept 2022 | Q2 FY22 30 Jun 2022 | Q1 FY22 31 Mar 2022 | Q4 FY21 31 Dec 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net income (loss) before noncontrolling interests | 6,645* | 5,290 | 5,423* | 5,609* | 5,522* | 4,804 | 5,263* | 5,170* | 4,909* | 4,623 | 3,510* | 5,736* | 4,903* | 4,880 | 2,628* | 3,500* | 2,952* | 3,802 | 6,399* |
| Provision for credit losses | 914* | 1,135 | 1,040* | 681* | 1,005* | 932 | 1,095* | 1,065* | 1,236* | 938 | 1,282* | 1,197* | 1,713* | 1,207 | 957* | 784* | 580* | -787 | -452* |
| Changes in fair value of MSRs and LHFS carried at fair value | 35* | 76* | 239 | -277* | 451* | 157* | -66 | 663* | -215* | -38* | 441 | 224* | -314* | -345* | -891 | -30* | |||
| Changes in fair value of MSRs and LHFS carried at fair value | 31* | 159 | |||||||||||||||||
| Depreciation, amortization and accretion | 1,877* | 1,836 | 2,123* | 1,839* | 1,893* | 1,858 | 1,984* | 1,783* | 1,972* | 1,819 | 1,494* | 1,597* | 1,628* | 1,552 | 1,579* | 1,690* | 1,772* | 1,791 | 1,800* |
| Deferred income tax benefit | -865* | -843 | -233* | -446* | -768* | -423 | 557* | -838* | -919* | 289 | -788* | 6* | 132* | 600 | 665* | 702* | -113* | -179 | 1,397* |
| Other, net | -297* | 299 | -184* | 388* | 2,653* | 3,372 | -5,551* | 5,877* | -119* | -1,944 | 7,202* | -3,323* | -433* | 3,703 | 3,750* | -6,203* | -5,955* | -6,116 | -1,890* |
| Originations and purchases of loans held for sale | -9,948* | -7,996 | -13,006* | -15,633* | -10,057* | -9,501 | -11,529* | -9,901* | -10,284* | -6,278 | -7,353* | -6,700* | -7,388* | -8,924 | -14,939* | -16,700* | -19,065* | -24,206 | -34,940* |
| Proceeds from sales of and paydowns on loans originally classified as held for sale | 11,459* | 6,041 | 15,728* | 11,610* | 7,717* | 8,627 | 11,093* | 8,336* | 7,340* | 5,055 | 6,453* | 6,955* | 5,609* | 7,776 | 10,514* | 13,281* | 23,299* | 18,324 | 22,937* |
| Trading assets and liabilities | -18,393* | 14,397 | -8,537* | -30,805* | -6,440* | -7,174 | 2,056* | 1,467* | -11,770* | -12,244 | 693* | 13,082* | -12,089* | 1,663 | 1,591* | 9,045* | 9,172* | 11,771 | 11,696* |
| Derivative assets and liabilities | 1,105* | -3,400* | -3,077 | 1,963* | -2,431* | -1,950* | -1,376 | -529* | -1,445* | 3,003* | 3,126 | 3,518* | 673* | 4,431* | -766 | 2,167* | |||
| Other assets | 1,001* | -9,004 | 3,394* | 13,833* | -8,296* | -13,037 | 4,198* | -6,861* | 8,907* | -3,052 | -654* | 2,249* | -960* | -7,473 | 1,536* | 3,090* | -7,948* | -5,815 | -1,259* |
| Other accrued expenses and liabilities | 14,351* | -2,171 | -7,036* | 10,915* | -1,121* | 2,343 | -1,948* | 88* | 2,571* | 111 | 6,229* | -3,634* | 3,165* | -1,145 | -4,778* | 2,468* | -1,192* | 3,271 | -1,150* |
| Net cash provided (used) by operating activities | 6,775* | 9,143 | 4,121* | -869* | -11,216* | -11,037 | 8,904* | 4,206* | 2,050* | -12,125 | 18,202* | 15,505* | -755* | 7,406 | 7,245* | 12,016* | 7,588* | 199 | 4,817* |
| Federal funds sold and securities borrowed or purchased under resale agreements | 10,254* | -21,670 | |||||||||||||||||
| Federal funds sold and securities purchased under resale agreements | -49,761* | 22,015* | -21,500 | -2,236* | -23,131* | -13,360* | 11,705 | -10,025* | -3,931* | 121* | 1,106 | -11,087* | -294* | 12,218* | -1,541 | 1,584* | |||
| Proceeds from sales | 3,389* | 8,639 | 2,818* | 1,904* | 2,357* | 97 | 12,694* | 10,448* | 233* | 4,526 | 659* | 4,086* | 9,906* | 0 | 1* | 1,564* | 15,311* | 19 | 3,390* |
| Paydowns and maturities | 6,168* | 7,236 | 5,070* | 5,742* | 5,204* | 4,821 | 8,075* | 10,503* | 7,670* | 8,083 | 4,142* | 3,404* | 4,505* | 2,821 | 2,967* | 4,974* | 4,974* | 6,876 | 14,621* |
| Purchases | -38,224* | -26,194 | -14,230* | -25,254* | -14,965* | -17,676 | -22,846* | -33,507* | -19,439* | -19,672 | -4,571* | -4,721* | -4,366* | -12,393 | -1,270* | -7,542* | -12,097* | -19,195 | -25,855* |
| Paydowns and maturities | 5,558* | 3,966 | 6,269* | 7,285* | 5,741* | 7,783 | 8,288* | 7,607* | 8,020* | 3,981 | 4,492* | 5,168* | 4,802* | 3,910 | 4,859* | 6,841* | 7,340* | 8,626 | 18,904* |
| Purchases | 0* | 0* | 0* | 0 | 0* | 0* | 0* | 4,225 | 0* | 0* | 65* | 2,295 | 11,765* | ||||||
| Proceeds from sales and capital returns | 1,227* | 1,146 | 1,193* | 795* | 1,943* | 620 | 808* | 1,156* | 1,098* | 750 | 564* | 411* | 793* | 476 | 594* | 642* | 1,179* | 1,911 | 2,227* |
| Purchases | -1,718* | -2,308 | -3,449* | -2,741* | -1,876* | -1,315 | -3,450* | -1,720* | -1,725* | -1,468 | -2,404* | -1,770* | -690* | -947 | -2,510* | -1,730* | -1,263* | -1,481 | -3,200* |
| Loans originated, net of principal collected | -19,634* | -32,317 | -45,122* | ||||||||||||||||
| Proceeds from sales of loans originally classified as held for investment | 3,683* | 1,050 | 1,118* | 766* | 827* | 956 | 1,159* | 1,332* | 575* | 565 | 1,128* | 532* | 1,027* | 1,588 | 1,512* | 2,763* | 4,028* | 4,143 | 5,459* |
| Loans originated, net of principal collected | -12,275* | -2,601 | -3,105* | 6,227* | 1,703* | 13,838 | 1,819* | 4,308* | 96* | 4,073 | -11,563* | -6,459* | -36,554* | -20,285 | -37,101* | ||||
| Purchases of loans | -120* | -519 | -675* | -392* | -208* | -380 | -441* | -102* | -69* | -231 | -272* | -457* | -493* | -415 | -237* | -128* | -276* | -100 | -76* |
| Other, net | -453* | 5,404 | 791* | -480* | -715* | 1,687 | 224* | -509* | -256* | 348 | -463* | 1,250* | 5,749* | -6,145 | 284* | -76* | 482* | 115 | 2,628* |
| Net cash provided (used) by investing activities | -29,870* | -55,567 | -85,570* | -82,865* | 8,048* | -27,508 | -1,064* | -21,098* | -14,584* | 21,095 | -4,231* | 7,628* | 20,601* | -7,955 | -15,926* | 919* | -4,508* | -22,961 | -31,402* |
| Principal collected on nonbank entities’ loans | 1,055* | 1,434* | 287 | 1,123* | 508* | 855* | 2,385 | 1,304* | 1,164* | 1,240* | 1,465 | 1,343* | |||||||
| Deposits | 46,466* | 28,737 | 58,950* | 26,658* | -21,025* | -10,076 | 22,158* | -16,248* | -17,253* | 24,974 | 4,163* | 9,426* | -18,045* | -21,356 | -14,170* | -26,998* | -56,201* | -1,125 | 12,100* |
| Loans originated by nonbank entities | -457* | -468* | -1,617 | -423* | -1,160* | -1,704* | -189 | -780* | -800* | -1,025* | -1,219 | -2,995* | |||||||
| Federal funds purchased and securities loaned or sold under repurchase agreements | 17,433* | 1,684 | |||||||||||||||||
| Short-term borrowings | 42,654* | 48,219* | 30,970 | -3,625* | -6,940* | 9,820* | 19,455 | -3,771* | 9,075* | 3,248* | 29,862 | 2,763* | 11,307* | 3,474* | -980 | -7,571* | |||
| Short-term borrowings | -7,114* | 13,959 | |||||||||||||||||
| Proceeds from issuance | 11,310* | 11,653 | 1,229* | 10,756* | 12,015* | 7,340 | 4,140* | 4,178* | 6,104* | 14,592 | 15,627* | 27,820* | 5,467* | 157 | 17,647* | 19,712* | 8,289* | 8,089 | 132* |
| Repayment | -11,995* | -1,326 | -3,184* | -9,344* | -12,324* | -9,618 | -6,806* | -7,836* | -14,335* | -26,605 | -6,638* | -4,036* | -7,054* | -5,158 | -2,395* | -5,214* | -4,089* | -7,889 | -2,395* |
| Proceeds from issuance | 0* | 2,246 | 0* | 0* | 0* | 0* | 0* | 0* | 0 | 0* | |||||||||
| Redeemed | -0* | -3,510 | -0* | -0* | -2,000* | -0 | -0* | -0* | -2,000* | -840 | -0* | -0* | -0* | -0* | -0 | -0* | |||
| Cash dividends paid | -247* | -248 | -248* | -248* | -305* | -249 | -307* | -233* | -332* | -227 | -345* | -239* | -337* | -220 | -338* | -219* | -338* | -220 | -338* |
| Repurchased | -3,015* | -4,000 | -5,000* | -6,000* | -3,016* | -3,500 | -4,000* | -3,435* | -6,012* | -6,001 | -2,350* | -1,480* | -4,005* | -4,016 | -6* | -5* | -4* | -6,018 | -7,012* |
| Cash dividends paid | -1,366* | -1,387 | -1,398* | -1,431* | -1,287* | -1,318 | -1,325* | -1,357* | -1,204* | -1,247 | -1,265* | -1,275* | -1,112* | -1,137 | -1,138* | -1,136* | -946* | -958 | -819* |
| Other, net | -189* | -704 | -51* | 72* | -154* | -728 | -301* | 114* | -70* | -527 | -56* | -123* | -21* | -309 | 20* | -67* | -20* | -472 | -108* |
| Net cash provided (used) by financing activities | 51,283* | 47,104 | 81,526* | 63,117* | 20,123* | 12,821 | 9,934* | -29,760* | -25,282* | 23,574 | 5,365* | 39,165* | -21,859* | -2,177 | 2,383* | -2,620* | -49,835* | -9,573 | -5,872* |
| Net change in cash, cash equivalents, and restricted cash | 28,188* | 680 | 77* | -20,617* | 16,955* | -25,724 | 17,774* | -46,652* | -37,816* | 32,544 | 19,336* | 62,298* | -2,013* | -2,726 | -6,298* | 10,315* | -46,755* | -32,335 | -32,457* |
| Cash, cash equivalents, and restricted cash at beginning of period | 173,273* | 172,593 | 172,516* | 193,133* | 176,178* | 201,902 | 184,128* | 230,780* | 268,596* | 236,052 | 216,716* | 154,418* | 156,431* | 159,157 | 165,455* | 155,140* | 201,895* | 234,230 | 266,687* |
| Cash, cash equivalents, and restricted cash at end of period | 201,461 | 173,273 | 172,593 | 172,516 | 193,133 | 176,178 | 201,902 | 184,128 | 230,780 | 268,596 | 236,052 | 216,716 | 154,418 | 156,431 | 159,157 | 165,455 | 155,140 | 201,895 | 234,230 |
| Cash paid for interest | 10,879* | 9,730 | 10,111* | 9,966* | 9,938* | 9,791 | 10,532* | 11,535* | 11,167* | 10,385 | 9,549* | 8,034* | 7,371* | 5,477 | 4,025* | 2,024* | 1,579* | 661 | 977* |
| Net cash paid (refunded) for income taxes | 209* | 514* | 120 | 1,558* | 527* | 1,434* | -1,855 | 150* | 48* | -1,157* | -827 | -487* | 46* | 3,741* | 76 | 52* | |||
| Reclassification of long-term debt to accrued expenses and other liabilities | 0* | 0* | 0* | 0 |